Breast Cancer - Jan 23, 2018 Edition

Health News and Information - News Medical

January 23, 2018     Breast Cancer     The latest breast cancer news from News Medical

FDA grants approval for first drug to treat inherited breast cancer   The U.S. Food and Drug Administration today expanded the approved use of Lynparza (olaparib tablets) to include the treatment of patients with certain types of breast cancer that have spread (metastasized)       When you need a breast screening, should you get a 3-D mammogram?   When I went to the imaging center for my regular mammogram last year, the woman behind the desk asked me if I'd like to get a "3-D" mammogram instead of the standard test I'd had in the past.

U.S. FDA approves first drug for patients with germline BRCA-mutated metastatic breast cancer   AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved LYNPARZA (olaparib) for use in patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have been previously treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting.         Exercise could extend the life expectancy of breast cancer survivors, study states   New research conducted by a group of scientists at the University of Southern California (USC), whose findings are published in the Journal of Clinical Oncology, suggests that regular exercise could extend the life expectancy of breast cancer survivors, by lowering their increased risk of type 2 diabetes, heart disease, and potentially breast cancer recurrence.         Exposure to estrogen-mimicking compounds may reverse effects of breast cancer treatment   Scientists from The Scripps Research Institute have discovered that two estrogen-mimicking compounds found in many foods appear to potently reverse the effects of palbociclib/letrozole, a popular drug combination for treating breast cancer.

Researchers block common siren call of glioblastoma and metastatic breast cancer   Aggressive cancers like glioblastoma and metastatic breast cancer have in common a siren call that beckons the bone marrow to send along whatever the tumors need to survive and thrive.       Study identifies genes involved in latent asymptomatic state of breast cancer metastases   The time needed for breast cancer metastases (secondary lesions caused by cells that have escaped from the original tumor) to develop varies between patients, and little is known about the mechanisms that govern latency (the dormant state of cells that have already spread through the body).       Researchers find new way to halt growth of breast cancer cells   An international team of researchers led from Karolinska Institutet and Science for Life Laboratory in Sweden have found a new way of halting the growth of breast cancer cells.       Research reveals cost-effectiveness of whole-population screening for breast, ovarian cancer gene mutations   Screening the entire population for breast and ovarian cancer gene mutations, as opposed to just those at high-risk of carrying this mutation, is cost effective and could prevent more ovarian and breast cancers than the current clinical approach, according to research published today in the Journal of the National Cancer Institute.       Study devises efficient and economical strategy to screen breast and ovarian cancer gene mutations   A new study published yesterday in the Journal of the National Cancer Institute suggests that, in comparison with just screening women who are at high risk of carrying breast and ovarian cancer gene mutations, screening the entire population for these mutations will be more cost-effective.

Website: www.news-medical.net Email: info@news-medical.net Telephone: +44 (0)161 457 7150 AZoNetwork UK Ltd. NEO, 4th Floor 9 Charlotte Street, Manchester M1 4ET, UK